Advancing U.S.-based cGMP manufacturing to support clinical and future commercial objectives of a novel siRNA therapy ...

Today, President Donald J. Trump imposed tariffs on patented pharmaceuticals and their ingredients under Section 232 of the ...

The hospital lobby is petitioning President Donald Trump to grant carve-outs for medical devices and pharmaceutical products to the tariffs his administration has enacted, or may soon enact, on Mexico ...

BY THE PRESIDENT OF THE UNITED STATES OF AMERICA A PROCLAMATION 1. The Secretary of Commerce (Secretary) recently transmitted to me a report on his ...

After weeks of speculation, President Donald Trump announced the administration’s plan for pharma tariffs and appeared to back down on the threat of significant action against the European Union. In a ...

Aurobindo's wholly owned subsidiary, Aurobindo Pharma USA, has entered into a collaboration and license agreement with an unnamed global pharma company for the development and commercialization of ...

The White House April 2 issued a proclamation implementing additional tariffs on certain patented pharmaceutical products and ...

For many years transporting high-value pharmaceutical products at <-60 degrees C for greater than 96 hours has seemed an insurmountable challenge for pharma and life science, but TOWER’s deep-frozen ...

As President Trump’s war in Iran rages on, it’s posing a growing threat to the pharmaceutical supply chain and risks spiking ...

Millions of eye drop products have been recalled over concerns they may not be sterile, according to an enforcement report ...